Comparative proteome analysis of breast cancer and normal breast
- PMID: 15767701
- DOI: 10.1385/MB:29:3:233
Comparative proteome analysis of breast cancer and normal breast
Abstract
Breast cancer is a leading cause of death for women. The underlying molecular mechanism is still not well understood. In this study, two-dimensional gel electrophoresis combined with mass spectrometry was used to analyze changes in the proteome of infiltrating ductal carcinoma compared to normal breast tissue. Ten sets of two-dimensional gels per experimental condition were analyzed and more than 500 spots each were detected. This revealed 39 spots for which expression in breast cancer cells were reproducibly altered more than twofold compared to normal controls (p < 0.01). These spots represented 25 different proteins after identification using the database search after mass spectrometry, comprising cell defense proteins, enzymes involved in glycolytic energy metabolism and homeostasis, protein folding and structural proteins, proteins involved in cytoskeleton and cell motility, and proteins involved in other functions. In addition, 28 nondifferentially expressed proteins with different functions were also mapped and identified, which might help to establish a two-dimensional gel electrophoresis reference map of human breast cancer. Our study shows that proteomics offers a powerful methodology to detect the proteins that show different expression patterns in breast cancer tissue and may provide an accurate molecular classification. The differentially expressed proteins may be used as potential candidate markers for diagnostic purposes or for determination of tumor sensitivity to therapy. The functional implications of the identified proteins are discussed.
Similar articles
-
Proteomic analysis of infiltrating ductal carcinoma tissues by coupled 2-D DIGE/MS/MS analysis.Mol Biol (Mosk). 2012 May-Jun;46(3):469-80. Mol Biol (Mosk). 2012. PMID: 22888636
-
Comparative proteomic analysis of ductal and lobular invasive breast carcinoma.Genet Mol Res. 2016 Apr 4;15(2). doi: 10.4238/gmr.15027701. Genet Mol Res. 2016. PMID: 27173185
-
Mass spectrometric characterization of protein structure details refines the proteome signature for invasive ductal breast carcinoma.J Am Soc Mass Spectrom. 2011 Mar;22(3):440-56. doi: 10.1007/s13361-010-0031-6. Epub 2011 Feb 8. J Am Soc Mass Spectrom. 2011. PMID: 21472563
-
Proteomics of breast cancer for marker discovery and signal pathway profiling.Proteomics. 2001 Oct;1(10):1216-32. doi: 10.1002/1615-9861(200110)1:10<1216::AID-PROT1216>3.0.CO;2-P. Proteomics. 2001. PMID: 11721634 Review.
-
[Search for breast cancer-related biomarker proteins for drug discovery].Yakugaku Zasshi. 2010 Dec;130(12):1701-6. doi: 10.1248/yakushi.130.1701. Yakugaku Zasshi. 2010. PMID: 21139398 Review. Japanese.
Cited by
-
Comparative proteome analysis of breast cancer and adjacent normal breast tissues in human.Genomics Proteomics Bioinformatics. 2006 Aug;4(3):165-72. doi: 10.1016/S1672-0229(06)60029-6. Genomics Proteomics Bioinformatics. 2006. PMID: 17127214 Free PMC article.
-
Novel insights into the structural requirements for the design of selective and specific aldose reductase inhibitors.J Mol Model. 2012 May;18(5):1791-9. doi: 10.1007/s00894-011-1195-0. Epub 2011 Aug 12. J Mol Model. 2012. PMID: 21833829
-
Breast cancer and protein biomarkers.World J Exp Med. 2012 Oct 20;2(5):86-91. doi: 10.5493/wjem.v2.i5.86. eCollection 2012 Oct 20. World J Exp Med. 2012. PMID: 24520539 Free PMC article.
-
Proteomic analysis of nipple aspirate fluid from women with early-stage breast cancer using isotope-coded affinity tags and tandem mass spectrometry reveals differential expression of vitamin D binding protein.BMC Cancer. 2006 Mar 16;6:68. doi: 10.1186/1471-2407-6-68. BMC Cancer. 2006. PMID: 16542425 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical